One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study. De Corso E, Corbi M, De Maio G, Mastrapasqua R, et al. Rhinology 2025;63:667-675.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

De Corso E, Corbi M, De Maio G, Mastrapasqua R, et al. One year mepolizumab outcomes in severe, uncontrolled CRSwNP: a real-life study. Rhinology 2025;63:667-675.
PMID: 40631514